Skip to main content
Equibles

SUSQUEHANNA INTERNATIONAL GROUP, LLP

Position in VRDN — Viridian Therapeutics, Inc.\DE

CIK 1446194 BALA CYNWYD, PA
Back to VRDN Full portfolio

Position in VRDN

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$2,393,317
+$1,331,659 QoQ
Shares Held
130,284
+140.0% QoQ
Ownership
0.115%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#75
of 215 holders
Holding Since
Sep 2021
20 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in VRDN Over Time

Shares Held

Position Value (USD)

Derivatives in VRDN

reported options exposure · as of Jun 30, 2026
CallValue
$856,042
CallShares
46,600
PutValue
$911,152
PutShares
49,600

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

SUSQUEHANNA INTERNATIONAL GROUP, LLP holds $1,653,301,875 across 349 Biotechnology names. VRDN ranks #77 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ABVX
Abivax S.A.
 1,053,896 $140,442,180
2 CYTK
Cytokinetics Inc
 1,549,458 $131,998,327
3 REGN
Regeneron Pharmaceuticals, Inc.
 180,219 $112,373,755
4 ALNY
Alnylam Pharmaceuticals, Inc.
 294,460 $88,641,293
5 MDGL
Madrigal Pharmaceuticals, Inc.
 148,610 $79,796,139
6 INSM
INSMED Inc
 729,354 $77,763,723
7 VRTX
Vertex Pharmaceuticals Inc / Ma
 144,174 $71,615,550
8 AGIO
Agios Pharmaceuticals, Inc.
 1,375,558 $51,046,957

All Filings in VRDN

Export CSV
49 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $856,042 46,600
2026-06-30 $2,393,317 130,284
2026-06-30 $911,152 49,600
2026-03-31 $3,405,396 174,100
2026-03-31 $1,061,658 54,277
2026-03-31 $4,563,348 233,300
2025-12-31 $896,256 28,800
2025-12-31 $510,368 16,400
2025-12-31 $3,626,225 116,524
2025-09-30 $211,484 9,800
2025-09-30 $812,271 37,640
2025-09-30 $1,027,208 47,600
2025-06-30 $1,761,801 126,023
2025-06-30 $3,239,166 231,700
2025-03-31 $1,482,584 109,984
2025-03-31 $136,148 10,100
2024-12-31 $4,046,787 211,100
2024-12-31 $1,430,082 74,600
2024-12-31 $1,837,732 95,865
2024-09-30 $1,726,929 75,909
2024-09-30 $1,690,325 74,300
2024-09-30 $2,263,625 99,500
2024-06-30 $640,235 49,211
2024-06-30 $304,434 23,400
2024-06-30 $965,342 74,200
2024-03-31 $371,212 21,200
2024-03-31 $953,244 54,440
2024-03-31 $1,458,583 83,300
2023-12-31 $551,034 25,300
2023-12-31 $296,208 13,600
2023-12-31 $551,426 25,318
2023-09-30 $485,464 31,647
2023-06-30 $1,855,620 78,000
2023-06-30 $5,816,655 244,500
2023-06-30 $4,995,804 209,996
2023-03-31 $2,348,773 92,326
2023-03-31 $396,864 15,600
2023-03-31 $1,325,424 52,100
2022-12-31 $1,308,608 44,800
2022-12-31 $452,871 15,504
2022-09-30 $498,105 24,286
2022-09-30 $559,923 27,300
2022-09-30 $875,777 42,700
2022-06-30 $367,926 31,800
2022-06-30 $1,009,528 87,254
2022-03-31 $1,803,274 97,527
2022-03-31 $719,261 38,900
2021-12-31 $547,629 27,700
2021-09-30 $282,940 17,200